<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="who use drugs. While the initial changes in regulation allowing" exact="buprenorphine" post="prescribing by telehealth are welcomed by providers and patients,"/>
 <result pre="to fill the gaps. Whether through efforts at opioid stewardship,1" exact="naloxone" post="distribution and education, initiation of treatment with buprenorphine,2 or"/>
 <result pre="Enforcement Administration (DEA) now allows patients to be initiated on" exact="buprenorphine" post="through a telemedicine visit, including telephone only.4 While this"/>
 <result pre="management and social work services are wholly feasible by phone." exact="Buprenorphine" post="prescribers in any setting (and especially the ED and"/>
 <result pre="ED and correctional facilities) should provide a longer duration of" exact="buprenorphine" post="prescriptions to create flexibility in coordinating follow up care."/>
 <result pre="of X-waivered providers, pharmacies have already served as locations for" exact="buprenorphine" post="initiation. During this pandemic, they should be recruited as"/>
 <result pre="should be recruited as accessible sites for the dispensation of" exact="naloxone" post="and possibly as hubs for telemedicine kiosks to access"/>
 <result pre="due to the COVID pandemic and the reduced barriers on" exact="buprenorphine" post="prescribing. While the initial changes in regulation to address"/>
 <result pre="incarceration. Health Justice2014; 2:5Published 2014 Mar 25. 8.JakubowskiAndreaFoxAaron. Defining Low-threshold" exact="Buprenorphine" post="Treatment. J Addict Med2020; 14(2):95â€&quot;98.31567596"/>
</results>
